IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS

被引：1262

作者：

FREIMAN, JA

CHALMERS, TC

SMITH, H

KUEBLER, RR

机构：

[1] CUNY,MT SINAI SCH MED,DEPT BIOSTAT,NEW YORK,NY 10029

[2] CUNY,MT SINAI SCH MED,OFF DEAN,NEW YORK,NY 10029

[3] UNIV N CAROLINA,SCH PUBL HLTH,DEPT BIOSTAT,CHAPEL HILL,NC 27514

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1978年 / 299卷 / 13期

关键词：

D O I：

10.1056/NEJM197809282991304

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：690 / 694

页数：5

共 8 条

[1]

[Anonymous], 1948, Br Med J, V2, P769

[2]

BURDETTE WJ, 1970, PLANNING ANAL CLIN S

[3]

CLAUSEN J, 1966, LANCET, V2, P920

[4]

Feinstein A., 1977, CLIN BIOSTATISTICS, P320

[5]

FLEISS JL, 1973, STATISTICAL METHODS, P176

[6] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39

[7] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].